Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis

Tan D.S.W.Geater S.CHONG-JEN YUTsai C.-M.Hsia T.-C.Chen J.Lin M.-C.Lu Y.Sriuranpong V.Yang C.-T.Sen P.Branle F.Shi M.Wu Y.-L.2022-06-272022-06-2720212666-3643https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109827725&doi=10.1016%2fj.jtocrr.2020.100131&partnerID=40&md5=101fa9a246d2020896fb626e2e96c67dhttps://scholars.lib.ntu.edu.tw/handle/123456789/613993Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysisjournal article10.1016/j.jtocrr.2020.1001312-s2.0-85109827725